Join the discussion — anonymously
Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.
Comments (2)
It is honestly exhausting to keep track of the headcount reductions at this point. Every time leadership mentions 'optimizing the portfolio,' those of us in the legacy departments just brace for the impact. The culture has shifted from innovation to constant survival mode, and it is impossible to stay motivated when your colleagues are being let go every few months. I miss when we actually focused on the science instead of just shuffling around the org chart to appease shareholders.
I understand the frustration, but these moves seem inevitable given the current pressure on the pipeline. BMS has been aggressive with these transitions for a while now, and while the human cost is undeniably high, it feels like the company is just doing whatever it takes to stay lean. It is brutal watching talent walk out the door, but at this stage, it feels like permanent instability is the new normal for everyone still sitting at their desks.